Meagan E. Miller, MD

Bio

I am originally from Kansas and attended medical school at KU School of Medicine. I was thrilled to move to Indianapolis in 2016, where I completed my Internal Medicine residency and am now a 3rd year Hematology/Oncology fellow at IU. I feel incredibly fortunate to call Indiana my home and can honestly say there is nowhere else I would rather be. I am actively involved in multiple clinical trials for lung cancer and different survivorship projects at IU and Riley Children's Hospital. In my free time, I like to read history books, take walks on one of Indy's many trails, and travel with my husband.

Key Publications

Meagan Miller, Nasser Hanna. "Non-Small Cell Lung Cancer: The Changing Landscape of Systemic Therapy." Accepted for publication in the British Medical Journal. 

Meagan Miller. "Gratitude in the Time of COVID."  Journal of Clinical Oncology 38, no. 35 (December 10, 2020) 4219-4220. DOI: 10.1200/JCO.20.02330. PMID: 33021867. 

Meagan Miller MD1, Nasser Hanna1*, Shadia Jalal1^, Salma K. Jabbour4, Robin Zon5, Goetz Kloecker6***, Michael Williamson7, Karen Reckamp8, Ebenezer Kio9, Robert Langdon10, Bamidele Adesunloye11, Ryan Gentzler12, Wael Harb13, Radhika Walling14, Christina Yeon8, Marianna Koczywas8, Greg Durm1**. "Phase II Trial of Concurrent Chemoradiation with Consolidation Pembrolizumab in Patients with Unresectable Stage III Non-Small Cell Lung Cancer: Survival Update and Analysis of Subsequent Treatment Strategies." Annals of Integrative Oncology 2021; 2(1): 1009.

Meagan E. Miller, Meera Patel, Sandra K. Althouse, Nasser Hanna, Hirva Mamdani. "The association between STK11 and/or KEAP1 mutations and response to PD-1/PD-L1 inhibitors in patients with advanced non-small cell lung cancer (NSCLC)." Journal of Clinical Oncology 2020; 38, no. 15_suppl. DOI: 10.1200/JCO.2020.38.15_suppl.e21538.